Development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles
Abstract Background Currently, the Bilayer tablets, Tablet in tablet and Inlay tablets composed of Glimepiride (GMP) and Pioglitazone (PGH) as immediate release part, and Metformin (MFH) as sustained-release part are available for the treatment of type II diabetes mellitus (T2DM). In these products,...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
SpringerOpen
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/077c1745a0ec4d43901d732766f6e1d7 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|